| 25-740 |
Susan I. Heath, Proposed Representative of the Estate of Henry A. Hurst, III, Deceased v. EcoHealth Alliance, Inc. |
Second Circuit |
2025-12-22 |
Pending |
diversity-jurisdiction erie-doctrine negligence public-health research-liability strict-liability |
Whether a federal court may determine negligence and strict liability claims in a diversity action involving novel claims of abnormally dangerous rese… |
| 25A103 |
National Institutes of Health, et al. v. American Public Health Association, et al. |
First Circuit |
2025-07-24 |
Presumed Complete |
administrative-law agency-discretion grant-termination judicial-review research-funding subject-matter-jurisdiction |
Whether federal agencies have unreviewable discretion to terminate scientific research grants without providing specific justification or adhering to … |
| 23-965 |
Jin-Pyong Peter Yim v. National Institutes of Health |
Third Circuit |
2024-03-06 |
Denied |
administrative-law agency-records agency-response foia-request freedom-of-information-act government-transparency non-exempt-records record-request record-specification responsive-records |
Must an agency specify which non-exempt records are responsive to a request? |
| 20-742 |
Steven Bruce v. Alex M. Azar, II, Secretary of Health and Human Services, et al. |
Ninth Circuit |
2020-11-30 |
Denied |
administrative-law due-process false-and-misleading fifth-amendment medically-acceptable-indications medicare-part-d ninth-circuit rehabilitation-act rehabilitation-act-section-504 |
Can the U.S. Court of Appeals for the Ninth Circuit sidestep issues under Medicare Part D by not looking behind a compendium's Medically Acceptable In… |
| 18-97 |
Marion Liu, Individually and as Successor in Interest to Augustine Liu, Deceased v. Janssen Research & Development, LLC |
California |
2018-07-23 |
Denied |
clinical-trials clinical-trials-regulation drug-safety duty-of-care duty-to-intervene federal-regulations human-subjects human-subjects-protection informed-consent medical-ethics medical-monitoring research-ethics |
Whether a drug company has a duty to stop a clinical study and refer a participant to medical care when it is aware the participant is suffering from … |